Download
https://www.ndtvprofit.com/business/glaxo-sanofi-said-to-discuss-620-million-u-k-vaccine-deal?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
GlaxoSmithKline and Sanofi are discussing a deal to supply the U.K. government with a potential coronavirus vaccine.
Share